VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Healthy adults 18-45 years of age                  │ Healthy adults 18-45 years of age                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Non-smoking                                        │ Non-smoking                                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Non-pregnant (post-menopausal, surgically sterile  │ Non-pregnant (post-menopausal, surgically sterile  │     100 │
│ or using effective contraceptive measures)         │ or using effective contraceptive measures)         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body mass index (BMI) less than or equal to 32     │ Body mass index (BMI) less than or equal to 32     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Medically healthy on the basis of medical history  │ Medically healthy on the basis of medical history  │     100 │
│ and physical examination                           │ and physical examination                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Completion of the screening process within 28 days │ Completion of the screening process within 28 days │     100 │
│ prior to dosing                                    │ prior to dosing                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Provision of voluntary written informed consent    │ Provision of voluntary written informed consent    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Recent participation (within 28 days) in other     │ Recent participation (within 28 days) in other     │     100 │
│ research studies                                   │ research studies                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Recent significant blood donation or plasma        │ Recent significant blood donation or plasma        │     100 │
│ donation                                           │ donation                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant or lactating                              │ Pregnant or lactating                              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Test positive at screening for human               │ Test positive at screening for human               │     100 │
│ immunodeficiency virus (HIV), hepatitis B surface  │ immunodeficiency virus (HIV), hepatitis B surface  │         │
│ antigen (HbsAg), or hepatitis C virus (HCV)        │ antigen (HbsAg), or hepatitis C virus (HCV)        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Recent (2-year) history or evidence of alcoholism  │ Recent (2-year) history or evidence of alcoholism  │     100 │
│ or drug abuse                                      │ or drug abuse                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History or presence of significant cardiovascular, │ History or presence of significant cardiovascular, │     100 │
│ pulmonary, hepatic, gallbladder or biliary tract,  │ pulmonary, hepatic, gallbladder or biliary tract,  │         │
│ renal, hematologic, gastrointestinal, endocrine,   │ renal, hematologic, gastrointestinal, endocrine,   │         │
│ immunologic, dermatologic, neurologic, or          │ immunologic, dermatologic, neurologic, or          │         │
│ psychiatric disease                                │ psychiatric disease                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who have used any drugs or substances     │ Subjects who have used any drugs or substances     │     100 │
│ known to inhibit or induce cytochrome (CYP) P450   │ known to inhibit or induce cytochrome (CYP) P450   │         │
│ enzymes and/or P-glycoprotein (P-gp) within 28     │ enzymes and/or P-glycoprotein (P-gp) within 28     │         │
│ days prior to the first dose and throughout the    │ days prior to the first dose and throughout the    │         │
│ study                                              │ study                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Drug allergies to quinine sulfate or rosiglitazone │ Drug allergies to quinine sulfate or rosiglitazone │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hemoglobin \> or = to 11.5g/dL                     │ Hemoglobin > or = to 11.5g/dL                      │      98 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Drug allergies to quinine sulfate or rosiglitazone │      39 │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 45 Years │ Healthy adults 18-45 years of age                  │      39 │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 93.11111111111111
OverAll Ratio: 95.05555555555556
